NovaBay Pharmaceuticals Inc (NBY) — Capital Reinvestment Ratio
Latest as of September 2017:
0.26x
NovaBay Pharmaceuticals Inc (NBY) has a Capital Reinvestment Ratio of 0.26x as of September 2017, meaning it reinvests 0% of its operating cash flow ($281.00K) in capital expenditures ($73.00K). See NBY cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.26x
Capex / Operating Cash Flow
Operating Cash Flow
$281.00K
USD
Capital Expenditures
$73.00K
USD
Data as of
Sep 2017
Most recent filing
NovaBay Pharmaceuticals Inc Capital Reinvestment Ratio (2006–2010)
This chart tracks NovaBay Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for NovaBay Pharmaceuticals Inc (2006–2010)
Year-by-year Capital Reinvestment Ratio for NovaBay Pharmaceuticals Inc from 2006 to 2010. For live market cap and broader valuation context, see NovaBay Pharmaceuticals Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.10x | $2.03 Million | $203.00K | ▲ +31.2% |
| 2006 | 0.08x | $4.74 Million | $362.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow